Zealand Pharma reports positive obesity drug trial results at diabetes conference

June 5, 2026 4:45 PM

Zealand Pharma A/S (NASDAQ: ZEAL) presented additional data from its Phase 2 ZUPREME-1 trial evaluating petrelintide for weight management at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found